Cook M - Search Results

1

Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis.

Zhang D, Shah NJ, Cook M, Blackburn M, Serzan MT, Advani S, Potosky AL, Atkins MB, Braithwaite D. Zhang D, et al. Among authors: cook m. Cancers (Basel). 2021 Dec 3;13(23):6109. doi: 10.3390/cancers13236109. Cancers (Basel). 2021. PMID: 34885219 Free PMC article.

2

Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer: A Systematic Review.

Cook MR, Kim C. Cook MR, et al. JAMA Oncol. 2019 Jul 1;5(7):1049-1054. doi: 10.1001/jamaoncol.2018.6737. JAMA Oncol. 2019. PMID: 30730549

3

Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection.

Shah NJ, Al-Shbool G, Blackburn M, Cook M, Belouali A, Liu SV, Madhavan S, He AR, Atkins MB, Gibney GT, Kim C. Shah NJ, et al. Among authors: cook m. J Immunother Cancer. 2019 Dec 17;7(1):353. doi: 10.1186/s40425-019-0771-1. J Immunother Cancer. 2019. PMID: 31847881 Free PMC article.

4

The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids.

Shah NJ, Cook MR, Wu T, Lev-Ari S, Blackburn MJ, Serzan MT, Alaoui A, Ahn J, Atkins MB. Shah NJ, et al. J Natl Compr Canc Netw. 2022 Jul;20(7):800-807.e1. doi: 10.6004/jnccn.2022.7020. J Natl Compr Canc Netw. 2022. PMID: 35830888

5

Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109.

Zhang D, Shah NJ, Cook M, Blackburn M, Serzan MT, Advani S, Potosky AL, Madhavan S, Belouali A, Atkins MB, Braithwaite D. Zhang D, et al. Among authors: cook m. Cancers (Basel). 2022 Sep 19;14(18):4525. doi: 10.3390/cancers14184525. Cancers (Basel). 2022. PMID: 36139703 Free PMC article.

6

Quality Assessment of a Systematic Review for HIV Infection and Advanced-Stage Cancer-In Reply.

Cook MR, Kim C. Cook MR, et al. JAMA Oncol. 2019 Sep 1;5(9):1370-1371. doi: 10.1001/jamaoncol.2019.2206. JAMA Oncol. 2019. PMID: 31318377 No abstract available.

7

Optimizing outcomes in primary mediastinal B-cell lymphoma: is R-CHOP enough?

Cook MR, Dunleavy K. Cook MR, et al. Blood Adv. 2021 Oct 12;5(19):3873-3875. doi: 10.1182/bloodadvances.2021005190. Blood Adv. 2021. PMID: 34507356 Free PMC article. No abstract available.

8

[No title available]

[No authors listed] [No authors listed] PMID: 35453143

9

Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19.

Cook MR, Dykes K, White K, Desale S, Agrawal R, Fernandez S, Huang X, Cobb NK, Lai C. Cook MR, et al. Clin Lymphoma Myeloma Leuk. 2022 Jul;22(7):e452-e458. doi: 10.1016/j.clml.2021.12.011. Epub 2021 Dec 26. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35058217 Free PMC article.

10

Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies.

Cook MR, Dunleavy K. Cook MR, et al. Curr Oncol Rep. 2022 Sep;24(9):1121-1131. doi: 10.1007/s11912-022-01250-y. Epub 2022 Apr 11. Curr Oncol Rep. 2022. PMID: 35403972 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,796 results

Search Page

Filters